CD133(−) Cells, Derived From a Single Human Colon Cancer Cell Line, Are More Resistant to 5-Fluorouracil (FU) Than CD133(+) Cells, Dependent on the β1-Integrin Signaling
Authors:
- Kumiko HongoKHKumiko Hongo
- Junichiro TanakaJTJunichiro Tanaka
- 1 June 2012
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 175 (2) , 278-288
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 48 references indexed in Scilit:
- Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620Experimental Cell Research, 2010
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancerBritish Journal of Cancer, 2010
- Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discoveryBritish Journal of Cancer, 2010
- Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell linesMolecular Cancer, 2009
- Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacityProceedings of the National Academy of Sciences, 2008
- CD133 expression is an independent prognostic marker for low survival in colorectal cancerBritish Journal of Cancer, 2008
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cellsOncogene, 2001